MARKET

RDHL

RDHL

Redhill Biopharm
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.600
+0.070
+1.55%
Closed 16:00 04/01 EDT
OPEN
4.410
PREV CLOSE
4.530
HIGH
4.630
LOW
4.410
VOLUME
96.38K
TURNOVER
--
52 WEEK HIGH
8.94
52 WEEK LOW
3.262
MARKET CAP
9.82M
P/E (TTM)
-3.3552
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average RDHL stock price target is 21.60 with a high estimate of 28.00 and a low estimate of 15.00.

EPS

RDHL News

More
  • Life Sciences Companies Investors Presentations Now Available for On-Demand Viewing
  • GlobeNewswire · 2d ago
  • With The World In The Midst Of A Pandemic, Attention Turns To Life Sciences
  • Benzinga · 03/25 21:56
  • RedHill Biopharma Provides Business Update
  • GlobeNewswire · 03/25 12:00
  • Covid-19-related activity - healthcare
  • Seeking Alpha - Article · 03/25 11:37

Industry

Biotechnology & Medical Research
-4.52%
Pharmaceuticals & Medical Research
-2.91%

Hot Stocks

Symbol
Price
%Change

About RDHL

RedHill Biopharma Ltd. is an Israel-based specialty biopharmaceutical company, primarily focused on the commercialization and development of proprietary drugs for the treatment of gastrointestinal diseases. The Company promotes the gastrointestinal drug Aemcolo in the United States (U.S.). Its key clinical late-stage development programs include: RHB-104, with positive results from a first Phase 3 study for Crohn's disease; RHB-204, with a planned pivotal Phase 3 study for pulmonary nontuberculous mycobacteria (NTM) infections; RHB-102 (Bekinda), with positive results from a Phase 3 study for acute gastroenteritis and gastritis and positive results from a Phase 2 study for IBS-D; ABC294640 (Yeliva), RHB-106, and RHB-107.
More

Webull offers kinds of RedHill Biopharma Ltd stock information, including NASDAQ:RDHL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RDHL stock news, and many more online research tools to help you make informed decisions.